2020 was an extraordinary year for the whole of humanity. But for the clinical research sector, it has proved to be particularly defining. Rising financial and time pressures on the life sciences industry will continue to drive changes in how clinical trials are conducted for many years to come. Rich Quelch at Origin discusses the positives which have come out of an extremely challenging year, professionally and personally.